Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats.

MLA

Mao, Qing, et al. “Nobiletin Protects against Myocardial Injury and Myocardial Apoptosis Following Coronary Microembolization via Activating PI3K/Akt Pathway in Rats.” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 392, no. 9, Sept. 2019, pp. 1121–30. EBSCOhost, https://doi.org/10.1007/s00210-019-01661-y.

APA

Mao, Q., Liang, X., Wu, Y., & Lu, Y. (2019). Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats. Naunyn-Schmiedeberg’s Archives of Pharmacology, 392(9), 1121–1130. https://doi.org/10.1007/s00210-019-01661-y

Chicago

Mao, Qing, Xiulin Liang, Yufu Wu, and Yongxiang Lu. 2019. “Nobiletin Protects against Myocardial Injury and Myocardial Apoptosis Following Coronary Microembolization via Activating PI3K/Akt Pathway in Rats.” Naunyn-Schmiedeberg’s Archives of Pharmacology 392 (9): 1121–30. doi:10.1007/s00210-019-01661-y.